Cargando…
The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b
Ciclesonide is an inhaled corticosteroid used to treat asthma and has been repurposed as a treatment for mildly ill COVID-19 patients, but its precise mechanism of action is unclear. Herein, we report that ciclesonide blocks the coronavirus-induced production of the cytokines IL-6, IL-8, and MCP-1 b...
Autores principales: | Lee, Yue-Zhi, Hsu, Hsing-Yu, Yang, Cheng-Wei, Lin, Yi-Ling, Chang, Sui-Yuan, Yang, Ruey-Bing, Liang, Jian-Jong, Chao, Tai-Ling, Liao, Chun-Che, Kao, Han-Chieh, Chang, Jang-Yang, Sytwu, Huey-Kang, Chen, Chiung-Tong, Lee, Shiow-Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325102/ https://www.ncbi.nlm.nih.gov/pubmed/35890406 http://dx.doi.org/10.3390/pharmaceutics14071511 |
Ejemplares similares
-
Correction: Lee et al. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 2022, 14, 1511
por: Lee, Yue-Zhi, et al.
Publicado: (2023) -
Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives
por: Yang, Cheng-Wei, et al.
Publicado: (2020) -
Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2
por: Hsu, Hsing-Yu, et al.
Publicado: (2021) -
Status of CLIC MBQ and DBQ Prototypes Procurement
por: Modena, Michele
Publicado: (2012) -
A Cross “Ethnical” Comparison of the Driver Behaviour Questionnaire (DBQ) in an Economically Fast Developing Country: DBQ in Arab Gulf and South Asian countries
por: Bener, Abdulbari, et al.
Publicado: (2013)